source
- TScan Therapeutics cuts 75% of staff to focus on preclinical solid tumor programsTScan Therapeutics said it will cut about three quarters of its workforce after pausing its hematological and autoimmune programs. The company will shift resources to its preclinical solid tumor p…
- EMA starts voluntary data-sharing pilot to boost confidence in new approach methods and cut animal testingThe European Medicines Agency announced a voluntary data submission pilot that allows drug developers to upload data generated by new approach methodologies (NAMs). The pilot is designed to build…